RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul B. Tchounwou to Tumor Suppressor Protein p53

This is a "connection" page, showing publications Paul B. Tchounwou has written about Tumor Suppressor Protein p53.
  1. Yedjou CG, Tchounwou PB. Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide. Mol Cell Biochem. 2009 Nov; 331(1-2):207-14.
    View in: PubMed
    Score: 0.289
  2. Kumar S, Tchounwou PB. p53 as a unique target of action of cisplatin in acute leukaemia cells. J Cell Mol Med. 2022 09; 26(17):4727-4739.
    View in: PubMed
    Score: 0.181
  3. Tchounwou PB, Yedjou CG, Dorsey WC. Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2). Cell Mol Biol (Noisy-le-grand). 2003 Nov; 49(7):1071-9.
    View in: PubMed
    Score: 0.049
  4. Dorsey WC, Tchounwou PB. CYP1a1, HSP70, P53, and c-fos expression in human liver carcinoma cells (HepG2) exposed to pentachlorophenol. Biomed Sci Instrum. 2003; 39:389-96.
    View in: PubMed
    Score: 0.046
  5. Dorsey WC, Tchounwou PB, Ford BD. Neuregulin 1-Beta cytoprotective role in AML 12 mouse hepatocytes exposed to pentachlorophenol. Int J Environ Res Public Health. 2006 Mar; 3(1):11-22.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support